ScholarIQanswers from OpenAlex

Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers

PaperCitations, authors & open-access status

Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers have?

ScholarIQcitation count

Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers has 168 citations in the OpenAlex counts ScholarIQ stores.

When was Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers published?

ScholarIQyear

Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers has 2025 year in the ScholarIQ index.

What is the open-access status of Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers?

ScholarIQoa status

Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers has closed oa status in the ScholarIQ index.

What is the DOI of Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers?

ScholarIQdoi

The DOI for Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers is on the source record.

What is the OpenAlex record for Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers?

ScholarIQopenalex

The OpenAlex for Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial